Company Profiles

driven by the PitchBook Platform

Acobiom

Acobiom
1999 FOUNDED
PRIVATE STATUS
1-10 EMPLOYEES
Early Stage VC LATEST DEAL TYPE
$1.76M LATEST DEAL AMOUNT
1 INVESTORS
Description

Developer of a technology designed to discover new transcriptomic biomarkers. The company's technology helps in developing and commercializing diagnostics and companion diagnostics (CDx), notably for personalized medicine applications and provides services in the fields of genomics, pharmacogenomics, and transcriptomics, for research purposes and clinical trials, enabling patients to be treated better.

Website
Formerly Known As
Skuldtech
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Discovery Tools (Healthcare)
Primary Office
1682, rue de la Valsière
CS 77394 Cap Delta, Biopole Euromédecine II
34184 Montpellier
France

+33 04 00 00 00 00
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Acobiom’s full profile, request a free trial.

Acobiom Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Early Stage VC 09-Jul-2014 $1.76M 000.00 Completed Generating Revenue
1. Early Stage VC 000.00 000.00 Completed Generating Revenue
To view this company’s complete deal history including valuation and funding, request access »

Acobiom Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Bpifrance Venture Capital Minority 000 0000 000000 0

Acobiom Executive Team (4)

Name Title Board
Seat
Contact
Info
Didier Ritter Founder & Chief Executive Officer
Philippe Outrebon Chief Financial Officer
david Piquemal Ph.D Chief Scientific Officer & Chief Technical Officer
Bernadette Trentin Ph.D Senior Project Manager & Head, Infectiology & Immunology Department
Questions or concerns about this profile? Reach out to website-support@pitchbook.com